BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Sun Pharmaceutical Industries Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524715
ISIN Demat
INE044A01036
Book Value (Rs)
93.2373503
NSE Symbol
SUNPHARMA
Divident Yield %
0.91
Market Cap
(Rs In Cr.)
422,427
P/E (TTM)
132.68
EPS (TTM)
13.27
Face Value
(Rs)
1
Back
Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter
31-Jul-26   Hrs IST

Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.63 crore during the previous quarter ended June 2025. Sales rose 10.14% to Rs 15183.55 crore in the quarter ended June 2026 as against Rs 13786.07 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales15183.5513786.07 10
OPM %29.1031.20 -
PBDT5041.624691.32 7
PBT4302.903990.77 8
NP2894.792278.63 27

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)